Work

Abstract 2834: Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-2834

Authors: Ryosuke Shirasaki, Sara Gandolfi, Ricardo De Matos Simoes, Geoffrey Matthews, Sondra Downey, Olga Dashevsky, Tang Huihui, Michal Sheffer, Eugen Dhimolea, Megan Bariteau, Jeffrey Sorrel, Nick Kwiatkowski, Thinghu Zhang, Nathanael Gray, Constantine Mitsiades

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2885581167

Cites:

Cited by: 1

Related to: 10